Beisland C - Search Results

1

Rules and regulations for a pregnant endourologist: the European perspective.

Juliebø-Jones P, Pietropaolo A, Spinoit AF, Bergesen AK, Guðbrandsdottir G, Beisland C, von Ostau N, Harke NN, Ribal MJ, Zerva M, Bres-Niewada E, Zondervan P, McLornan L, Ferretti S, Tonnhofer U, Necknig UH, Skolarikos A, Somani BK. Juliebø-Jones P, et al. Among authors: beisland c. World J Urol. 2022 Mar;40(3):857-864. doi: 10.1007/s00345-021-03896-y. Epub 2021 Dec 7. World J Urol. 2022. PMID: 34874462 Free PMC article.

2

A phase I prospective, non-randomized trial of autologous dendritic cell-based cryoimmunotherapy in patients with metastatic castration-resistant prostate cancer.

Thomsen LCV, Honoré A, Reisæter LAR, Almås B, Børretzen A, Helle SI, Førde K, Kristoffersen EK, Kaada SH, Melve GK, Haslerud TM, Biermann M, Bigalke I, Kvalheim G, Azeem W, Olsen JR, Gabriel B, Knappskog S, Halvorsen OJ, Akslen LA, Bahn D, Pantel K, Riethdorf S, Ragde H, Gjertsen BT, Øyan AM, Kalland KH, Beisland C. Thomsen LCV, et al. Among authors: beisland c. Cancer Immunol Immunother. 2023 Jul;72(7):2357-2373. doi: 10.1007/s00262-023-03421-7. Epub 2023 Mar 20. Cancer Immunol Immunother. 2023. PMID: 36939854 Free PMC article. Clinical Trial.

3

Identifying possible biomarkers of lower urinary tract symptoms using metabolomics and partial least square regression.

Hopland-Nechita FV, Andersen JR, Rajalahti TK, Andreassen T, Beisland C. Hopland-Nechita FV, et al. Among authors: beisland c. Metabolomics. 2023 Sep 12;19(9):82. doi: 10.1007/s11306-023-02046-2. Metabolomics. 2023. PMID: 37698748 Free PMC article.

4

Microvascular proliferation is associated with high tumour blood flow by mpMRI and disease progression in primary prostate cancer.

Børretzen A, Reisæter LAR, Ringheim A, Gravdal K, Haukaas SA, Fasmer KE, Haldorsen IHS, Beisland C, Akslen LA, Halvorsen OJ. Børretzen A, et al. Among authors: beisland c. Sci Rep. 2023 Oct 20;13(1):17949. doi: 10.1038/s41598-023-45158-4. Sci Rep. 2023. PMID: 37863961 Free PMC article.

5

Obesity is associated with an improved cancer-specific survival, but an increased rate of postoperative complications after surgery for renal cell carcinoma.

Rogde AJ, Gudbrandsdottir G, Hjelle KM, Sand KE, Bostad L, Beisland C. Rogde AJ, et al. Among authors: beisland c. Scand J Urol Nephrol. 2012 Oct;46(5):348-57. doi: 10.3109/00365599.2012.678382. Epub 2012 Apr 25. Scand J Urol Nephrol. 2012. PMID: 22530756

6

Incidentally detected renal cell carcinomas are highly associated with comorbidity and mortality unrelated to renal cell carcinoma.

Sand KE, Hjelle KM, Rogde ÅJ, Gudbrandsđottir G, Bostad L, Beisland C. Sand KE, et al. Among authors: beisland c. Scand J Urol. 2013 Dec;47(6):462-71. doi: 10.3109/21681805.2013.777364. Epub 2013 Mar 21. Scand J Urol. 2013. PMID: 23517346

7

Contemporary external validation of the Leibovich model for prediction of progression after radical surgery for clear cell renal cell carcinoma.

Beisland C, Gudbrandsdottir G, Reisæter LA, Bostad L, Wentzel-Larsen T, Hjelle KM. Beisland C, et al. Scand J Urol. 2015 Jun;49(3):205-10. doi: 10.3109/21681805.2014.980844. Epub 2014 Nov 25. Scand J Urol. 2015. PMID: 25423093

8

Preoperative high levels of serum vascular endothelial growth factor are a prognostic marker for poor outcome after surgical treatment of renal cell carcinoma.

Guðbrandsdottir G, Hjelle KM, Frugård J, Bostad L, Aarstad HJ, Beisland C. Guðbrandsdottir G, et al. Among authors: beisland c. Scand J Urol. 2015;49(5):388-94. doi: 10.3109/21681805.2015.1021833. Scand J Urol. 2015. PMID: 25773545

9

A prospective risk-stratified follow-up programme for radically treated renal cell carcinoma patients: evaluation after eight years of clinical use.

Beisland C, Guðbrandsdottir G, Reisæter LA, Bostad L, Hjelle KM. Beisland C, et al. World J Urol. 2016 Aug;34(8):1087-99. doi: 10.1007/s00345-016-1796-4. Epub 2016 Feb 27. World J Urol. 2016. PMID: 26922650

10

Serum levels of the IL-6 family of cytokines predict prognosis in renal cell carcinoma (RCC).

Gudbrandsdottir G, Aarstad HH, Bostad L, Hjelle KM, Aarstad HJ, Bruserud Ø, Tvedt THA, Beisland C. Gudbrandsdottir G, et al. Among authors: beisland c. Cancer Immunol Immunother. 2021 Jan;70(1):19-30. doi: 10.1007/s00262-020-02655-z. Epub 2020 Jul 3. Cancer Immunol Immunother. 2021. PMID: 32621022 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

149 results

Search Page

Filters